KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Other Non-Current Assets (2016 - 2026)

Pfizer has reported Other Non-Current Assets over the past 18 years, most recently at $9.8 billion for Q1 2026.

  • Quarterly Other Non-Current Assets changed 0.11% to $9.8 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $9.8 billion through Mar 2026, changed 0.11% year-over-year, with the annual reading at $9.6 billion for FY2025, 1.89% down from the prior year.
  • Other Non-Current Assets was $9.8 billion for Q1 2026 at Pfizer, up from $9.6 billion in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $13.2 billion in Q4 2022 and troughed at $7.7 billion in Q3 2022.
  • The 5-year median for Other Non-Current Assets is $9.8 billion (2025), against an average of $10.4 billion.
  • Year-over-year, Other Non-Current Assets soared 71.42% in 2022 and then decreased 21.28% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $13.2 billion in 2022, then decreased by 5.26% to $12.5 billion in 2023, then fell by 21.28% to $9.8 billion in 2024, then fell by 1.89% to $9.6 billion in 2025, then grew by 2.11% to $9.8 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Other Non-Current Assets are $9.8 billion (Q1 2026), $9.6 billion (Q4 2025), and $9.3 billion (Q3 2025).